Teva Pharmaceuticals has received US FDA approval for AJOVY (fremanezumab-vfrm) as a preventive treatment for episodic migraine in children and adolescents aged 6–17 who weigh at least 45 kilograms.

Ahmedabad: Senores Pharmaceuticals Limited, through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA, has ...

Half Year Results/Half Year ReportFormycon confirms full-year guidance following business development in line with plan – working capital raised 13.08.2025 / 06:30 CET/CESTThe issuer is solely ...

Senores Pharmaceuticals rose 2.16% to Rs 687.75 after its US arm signed a deal to acquire two USFDA-approved ANDAs from Teva Pharmaceuticals USA, targeting a market size of up to $120 million.

Teva Pharmaceutical Industries (NYSE:TEVA) shares continued gains for seven straight sessions, as the stock closed 1% higher ...

The FDA has approved Ajovy for migraine prevention in children and teens, marking the first time a medication in its class is cleared for pediatric use.

The spinout, known as Celea Therapeutics, will advance what’s designed to be an improved version of the drug pirfenidone for ...

Using its hub-and-spoke business model, PureTech is launching a new company to develop deupirfenidone (LYT-100), its ...

PureTech has promoted Sven Dethlefs, who has been involved in the drug's development over the past year, to lead Celea. Dethlefs is the ex-chief executive of North America at Teva Pharmaceuticals ...

ProPublica identified more than 150 products that were exempted from import bans since 2013. Our list provides the names of ...

Schuyler County will receive up to $38,000 from a settlement with drug company Sandoz, Inc. and its affiliates over claims tied to the opioid crisis. The county legislature approved the settlement ...

The page may have been moved or deleted. You can try searching for it below, move on or ask for help.